DUBLIN, IRELAND--(MARKET WIRE)--Aug 30, 2007 -- Trinity Biotech plc (NasdaqGS:TRIB - News) (DUBLIN: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced Brendan Farrell, President, will be speaking at the Roth Capital Partners New York Conference at 3:00 pm Eastern Time, on Wednesday the 5th of September. The event will be webcast and can be accessed on http://www.roth.com/main/Page.aspx?PageID=7010
